Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-steroidal therapeutics for the treatment of chronic pain, today announced the successful completion of a $67 million Series D financing.
{iframe}http://www.4-traders.com/news/Centrexion-Therapeutics-Raises-67-Million-Launching-Phase-3-Program-for-CNTX-4975-in-Knee-Osteoart–25739300/?{/iframe}